This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignees: Centre National De La Recherche Scientifique, The University of Nantes, Université Du Mans. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:


Years Active: 2025
Title: Fabrice Fleury: Innovator in Proliferative Disease Treatment
Introduction
Fabrice Fleury is a notable inventor based in Orvault, France. He has made significant contributions to the field of medicine, particularly in the treatment of proliferative diseases. His innovative work has led to the development of a unique patent that addresses critical health challenges.
Latest Patents
Fabrice Fleury holds a patent for "Disulfonate stilbenes for use in the treatment of proliferative diseases." This patent includes compounds of a general formula where R and R' are independently selected from hydrogen and pharmaceutically acceptable cations. Additionally, R and R' are identical and selected from amide, carbamate, sulphonamide, azido, cyano, and halide. The patent also describes a pharmaceutical composition that may include another active ingredient, particularly an antineoplastic agent. This composition is intended for use as a medicament, especially in the treatment of proliferative diseases such as cancer. He has 1 patent to his name.
Career Highlights
Fabrice Fleury has worked with esteemed institutions such as the University of Nantes and the Centre National de la Recherche Scientifique. His career reflects a commitment to advancing medical research and developing effective treatments for serious health conditions.
Collaborations
Fabrice has collaborated with notable colleagues, including Alexandre Demeyer and Pierre Weigel. These partnerships have contributed to his innovative research and development efforts.
Conclusion
Fabrice Fleury's work in the field of proliferative disease treatment showcases his dedication to medical innovation. His patent and collaborations highlight his significant contributions to advancing healthcare solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile